San Mateo Atenco, Mexico

Nydia Lopez

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Teva Pharmaceuticals International Gmbh. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nydia Lopez. Retrieved from https://idiyas.com/inventor/nydia-lopez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nydia Lopez: Innovator in Pharmaceutical Science

Introduction

Nydia Lopez is a prominent inventor based in San Mateo Atenco, Mexico. She has made significant contributions to the field of pharmaceutical science, particularly in the development of solid-state forms of selexipag. Her work is crucial for advancing treatment options in various medical conditions.

Latest Patents

Nydia Lopez holds 1 patent for her innovative work titled "Solid state forms of selexipag." This patent focuses on the solid-state forms IV and V of selexipag, detailing the processes for their preparation, pharmaceutical compositions, and methods of use. This advancement is expected to enhance the efficacy and stability of selexipag in therapeutic applications.

Career Highlights

Nydia is currently employed at Teva Pharmaceuticals International GmbH, where she continues to push the boundaries of pharmaceutical research. Her expertise and dedication to innovation have positioned her as a valuable asset in her field.

Collaborations

Nydia has collaborated with notable colleagues, including Ales Gavenda and Hana Kantor. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research.

Conclusion

Nydia Lopez exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions, particularly in the development of solid-state forms of selexipag, highlight her commitment to improving healthcare solutions. Her work continues to inspire future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…